Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers

6 de July, 2023

Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the bystander killing effect and be effective

⟵ Should Astros Entertain This Trade Proposal From Red Sox? – Sports Illustrated

Murena Fairphone 4 debuts in the US with deGoogled operating system ⟶

4.3 million Americans exposed in massive health savings account data breach

Health savings account (HSA) provider HealthEquity experienced a massive data breach that has put over 4.3 million Americans’ information at risk. The company, which specializes in providing HSAs, flexible spending accounts (FSAs), health reimbursement arrangements (HRAs) and 401(k) retirement plans, confirmed threat actors stole sensitive health data using a partner’s compromised credentials. This includes full […]

Rare ‘Sharktopus’ – an octopus riding a shark – sighting caught on camera shared by scientists

What happens when an octopus jumps on a shark for a ride around town? A “sharktopus,” of course. The rare sighting, captured on video off the coast of New Zealand and shared by scientists affiliated with the University of Auckland, shows a Maori octopus riding on top of a mako shark, which is the fastest […]

Online marketplaces, social media platforms under fire by Congress over recalled products

Imagine that you ordered something online and found out later that it was recalled or even banned. How would you react? Would you ever buy from that online retailer again? Probably not. That is the scenario that the House Energy and Commerce Committee wants to prevent. The committee is worried that some of the largest […]